Luis A Barrera Selected Research

Keratan Sulfate

1/2015	Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
12/2012	Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.
9/2010	Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.
9/2008	[Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].
4/2004	Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
1/2004	Identification of a common mutation in mucopolysaccharidosis IVA: correlation among genotype, phenotype, and keratan sulfate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis A Barrera Research Topics

Disease

12	Mucopolysaccharidoses 05/2020 - 01/2004
11	Mucopolysaccharidosis IV (Morquio Syndrome) 01/2020 - 01/2004
5	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2016 - 04/2004
3	Mucopolysaccharidosis II (Hunter Syndrome) 04/2013 - 06/2005
2	Disease Progression 12/2012 - 02/2010
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 12/2020
1	Metabolic Diseases (Metabolic Disease) 05/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Tay-Sachs Disease 01/2018
1	Coarse facial features 02/2015
1	Congenital Abnormalities (Deformity) 02/2015
1	Bone Diseases (Bone Disease) 02/2015
1	Umbilical Hernia (Omphalocele) 02/2015
1	Infections 02/2015
1	Intellectual Disability (Idiocy) 02/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2013
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 12/2012
1	Lung Diseases (Lung Disease) 12/2012
1	Pathologic Constriction (Stenosis) 12/2012
1	Pneumonia (Pneumonitis) 12/2012
1	Developmental Bone Diseases (Bone Dysplasia) 12/2012
1	Apnea 12/2012
1	Mucolipidoses (Sialidosis) 02/2010

Drug/Important Bio-Agent (IBA)

9	SulfatasesIBA 01/2020 - 01/2004
6	Keratan SulfateIBA 01/2015 - 01/2004
5	EnzymesIBA 05/2020 - 03/2007
4	GlycosaminoglycansIBA 05/2020 - 02/2010
2	Hexosaminidases (Hexosaminidase)IBA 12/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2015
2	iduronate 2-sulfateIBA 04/2013 - 06/2005
2	Sulfates (Sulfates, Inorganic)IBA 04/2013 - 03/2007
1	GangliosidesIBA 12/2020
1	LipidsIBA 01/2018
1	Hexosaminidase A (Hex A)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Tocopherols (Tocopherol)IBA 01/2018
1	CyclodextrinsIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Lysergic Acid Diethylamide (LSD)IBA 01/2016
1	human GALNS proteinIBA 11/2015
1	Recombinant ProteinsIBA 04/2013
1	Anesthetics (Anesthetic Agents)IBA 12/2012
1	Complementary DNA (cDNA)IBA 09/2010
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 09/2010
1	mutalipocin IIIBA 02/2010
1	Heparitin Sulfate (Heparan Sulfate)IBA 02/2010
1	DisaccharidesIBA 02/2010
1	Dermatan SulfateIBA 02/2010
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Iduronic Acid (Iduronate)IBA 03/2007
1	CreatinineIBA 04/2004

Therapy/Procedure

8	Therapeutics 12/2020 - 02/2010
7	Enzyme Replacement Therapy 12/2020 - 11/2010
1	Orthopedic Procedures 01/2015
1	Hematopoietic Stem Cell Transplantation 01/2015
1	Anesthesia 12/2012
1	Complementary Therapies (Alternative Medicine) 09/2008